| Market Cap | ₹7,260Cr | 
| ROE | 11.10% | 
| P/E Ratio(TTM) | 20.91 | 
| EPS(TTM) | 22.06 | 
| P/B Ratio | 2.38 | 
| Dividend Yield | 0.00% | 
| Industry P/E | 34.63 | 
| Book Value | 193.65 | 
| Debt to Equity | 0.03 | 
| Face Value | 2 | 
| Parent Organisation | Akums Drugs And Pharmaceuticals | 
| NSE Symbol | AKUMS | 
| COMPANY | 52 WEEK  | MARKET PRICE | P/E Ratio  | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%)  | 87.58  | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%)  | 38.40  | ||
| Emcure Pharmaceuticals | NA (0.00%)  | 32.46  | ||
| Wockhardt | NA (0.00%)  | -139.73  |